Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflammatory response in ICU patients receiving TPN: SMOF lipid 20% versus Intralipid 20%
PACTR201405000821398Recruiting
- Sponsor
- Medical Research Institute
- Start
- Jun 2014
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of SMOFlipid and Intralipid 10% in postoperative state after abdominal surgery (2 arms), sponsored by Medical Research Institute. Primary endpoint: Impact of either mixture on inflammatory response. Started Jun 2014; status: recruiting.
02
Drugs
SMOFlipidIntralipid 10%
03
Conditions
postoperative state after abdominal surgery
Beyond the preview
Go deeper on PACTR201405000821398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201405000821398.